Tenon Medical (TNON) EBITDA (2021 - 2026)

Tenon Medical's EBITDA history runs 6 years deep, the most recent figure standing at -$3.3 million for Q1 2026.

• In Q1 2026, EBITDA rose 9.29% year-over-year to -$3.3 million; the TTM figure through Mar 2026 stood at -$12.2 million (up 10.89% YoY), while the FY2025 annual figure was -$12.6 million, up 7.86% from the prior year.
• EBITDA was -$3.3 million for Q1 2026 at Tenon Medical, down from -$2.8 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$2.4 million in Q1 2022 to a low of -$7.8 million in Q4 2022.
• Historically, EBITDA has averaged -$3.8 million across 5 years, with a median of -$3.3 million in 2025.
• The sharpest annual moves came in 2022 and 2023: EBITDA sank 1076.5% in 2022, then soared 60.72% in 2023.
• A 5-year view of EBITDA shows it stood at -$7.8 million in 2022, then jumped by 60.72% to -$3.1 million in 2023, then decreased by 0.29% to -$3.1 million in 2024, then gained by 8.26% to -$2.8 million in 2025, then retreated by 15.82% to -$3.3 million in 2026.
• The last three EBITDA figures came in at -$3.3 million (Q1 2026), -$2.8 million (Q4 2025), and -$3.3 million (Q3 2025), per Business Quant data.